.Pharmacolibrary.Drugs.D_Dermatologicals.D05A_AntipsoriaticsForTopicalUse.D05AD02_Methoxsalen.Methoxsalen .Pharmacolibrary.Drugs.D_Dermatologicals.D05A_AntipsoriaticsForTopicalUse.D05AD02_Methoxsalen.Methoxsalen| name: | Methoxsalen | |
| ATC code: | D05AD02 | route: | oral |
| compartments: | 1 | |
| dosage: | 20 | mg |
| volume of distribution: | 1.2 | L |
| clearance: | 0.6 | L/h/kg |
| other parameters in model implementation | ||
Methoxsalen is a furocoumarin and photosensitizing agent used in combination with ultraviolet A (UVA) light for the treatment of skin disorders such as psoriasis, vitiligo, and cutaneous T-cell lymphoma (CTCL) in PUVA therapy. It is an FDA-approved medication.
Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose.
Micheal, F, et al., & Motial, BM (2021). Assessment of Prescribability and Switchability by Using Multiple Bioequivalence Assessment Approaches. Drug metabolism letters 14(2) 141–151. DOI:10.2174/1872312814666210319124659 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33745439